Kazakhstan and The British-Swedish Pharmaceutical Company Astrazeneca Signed a MoU


During the ninth meeting of the Kazakh-British Intergovernmental Commission on Trade, Economic, Scientific, Technical and Cultural Cooperation, held on February 7 in London, the Ministry of Health of Kazakhstan signed a Memorandum of Cooperation with the British-Swedish biopharmaceutical company AstraZeneca. This was reported to Sng.today by  the press service of the Kazakh Ministry of Health.

Timur Sultangaziyev, First Vice Minister of Health, who participated in the meeting, noted that the document will contribute to the development of the pharmaceutical industry in Kazakhstan, including increasing the availability of innovative medicines for the country’s residents, and encouraging manufacturers to expand contract manufacturing of medicines at production facilities located on the territory of the republic.

It was noted that the deepening of cooperation with AstraZenesa will help further integration of modern and effective international practices into the country’s healthcare system, strengthening interstate cooperation and exchange of experience in the field of healthcare, medical science and education between Kazakhstan and the UK.

As part of the signing of the Memorandum, the possibility of assisting a British pharmaceutical company in the localization of innovative drugs based on Kazakhstani production was considered.

Source: SNG Today